药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Alizapride
Latamoxef
Latamoxef may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
Alizapride
Cephalothin Group
Cephalothin Group may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
Alizapride
Hydrolyzed Cephalothin
Hydrolyzed Cephalothin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
Alizapride
Etoricoxib
Etoricoxib may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
Alizapride
Tiaprofenic acid
Tiaprofenic acid may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
Alizapride
Propacetamol
Magnesium carbonate can cause a decrease in the absorption of Propacetamol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Cyclopentamine
The risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Cyclopentamine.
Alizapride
Hexamethonium
The risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Hexamethonium.
Alizapride
Magnesium stearate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium stearate.
Alizapride
Magnesium acetate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium acetate.
Alizapride
Magnesium glycinate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium glycinate.
Alizapride
Magnesium acetate tetrahydrate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium acetate tetrahydrate.
Alizapride
Magnesium citrate
The risk or severity of neuromuscular blockade can be increased when Magnesium citrate is combined with Magnesium carbonate.
Alizapride
Magnesium phosphate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium phosphate.
Alizapride
Magnesium orotate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium orotate.
Alizapride
Magnesium gluconate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium gluconate.
Alizapride
Magnesium aspartate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium aspartate.
Alizapride
Magnesium silicate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium silicate.
Alizapride
Magnesium Aluminum Silicate
The risk or severity of neuromuscular blockade can be increased when Magnesium carbonate is combined with Magnesium Aluminum Silicate.
Alizapride
Viomycin
The risk or severity of neuromuscular blockade can be increased when Viomycin is combined with Magnesium carbonate.